Trial Profile
A Safety and Immunogenicity Evaluation of a Meningococcal (Groups A, C, Y, and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine (Menactra) and a Meningococcal Polysaccharide Vaccine Groups A, C, Y, and W-135 Combined (Menomune - A/C/Y/W-135) in Subjects 56 Years of Age or Older.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 25 Jun 2013
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary) ; Meningococcal vaccine groups A C Y W-135 polysaccharide (Primary)
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; Meningococcal infections
- Focus Adverse reactions; Pharmacodynamics
- 22 Jun 2012 Additional trial identifier (U1111-1115-6685) identified as reported by ClinicalTrials.gov.(Extension trial; NCT01239043).
- 22 Jun 2012 Additional trial identifier (U1111-1115-6685) identified as reported by ClinicalTrials.gov.(Extension trial; NCT01239043).
- 02 Apr 2012 Actual patient number is 129 as reported by ClinicalTrials.gov (Extension trial; NCT01239043).